Sign The Petition To Bring The Lymphoma Vaccine to Market

Today I'm very pleased to be writing about a movement to grant accelerated approval to the therapeutic lymphoma vaccine BiovaxID.

This past July I wrote about BiovaxID and was intrigued by its potential. I wasn't alone in fully expecting the FDA to grant accelerated approval to Biovest for the vaccine.

Instead, the FDA said Biovest needed to carry out another confirmatory trial, delivering a significant blow to the company and the many thousands of patients who could benefit. I began writing BiovaxID: On the Trail of the Follicular Lymphoma Vaccine, a multi-part look at this therapeutic vaccine from several angles. It's a series I've not yet finished.

Then the other day I received the news from my colleague Liz Hart McMillan that a petition had been launched by patients, caregivers, patient advocates and physicians not connected with either the clinical trials nor Biovest to press the government to grant accelerated approval to BiovaxID. Accelerated approval simply means that the FDA allows the vaccine to reach the market, but the company must still carry out a confirmatory trial.

There is a longer and more detailed explanation at the petition page.

McMillan, who is coordinating the campaign, is a 6-year diffuse large B-cell lymphoma (DLBCL) survivor. She is also the founder of support groups for both follicular lymphoma and mantle cell lymphoma patients, the founder of Hope for Lymphoma (now 16 private Facebook support and education groups) and an advocate who coordinates educational symposia for lymphoma patients at medical centers across the United States featuring key lymphoma thought leaders. The petition--the drive itself--couldn't possibly be in better hands.

Learn More

BiovaxID is an important therapeutic vaccine that can greatly improve the quality of life of patients with follicular lymphoma. It is not a cure. But it is a much better way of treating these patients after they have had frontline chemotherapy than the current standard of care.

BiovaxID is an autologous vaccine. This means that the vaccine is created from the patient's own tumor cell—not from mice or anything else that is foreign to the body and could cause an allergic reaction.

You can access the petition HERE.

You can read more about BiovaxID through an excellent write-up on the vaccine and the petition by author and advocate Betsy de Parry, as well as through my own ongoing series BiovaxID: On the Trail of the Follicular Lymphoma Vaccine.

You can also visit the Biovest website for more information.

The petition still needs more signatures. I hope you'll consider visiting the page and adding yours.

More Articles

More Articles

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

Canine lymphoma, just like lymphoma in humans, can be separated into stages,...